SCHEMBL7988952

SCHEMBL7988952

Cc1cccc(Cn2cnc3nc(-c4cccc(F)c4)[nH]c(=O)c32)c1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.43
GRIN2B Q13224 2/20 0.43
HPGD P15428 3/20 0.43
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
POLB P06746 2/20 0.42
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
ACP1 P24666 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MET P08581 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991667 0.93 ALDH1A1 (0.46) GRIN1GRIN2BHPGDALDH1A1SMN1; SMN2
SCHEMBL7988564 0.91 HPGD (0.47) GRIN1GRIN2BHPGDALDH1A1SMN1; SMN2
SCHEMBL7974466 0.91 HPGD (0.43) GRIN1GRIN2BHPGDALDH1A1SMN1; SMN2
SCHEMBL7974266 0.90 ALDH1A1 (0.50) HPGDALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL7987251 0.90 SMN1; SMN2 (0.53) HPGDALDH1A1SMN1; SMN2KMT2AACP1
SCHEMBL7991556 0.89 HPGD (0.43) HPGDALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL7987307 0.88 GRIN1 (0.46) GRIN1GRIN2BHPGDALDH1A1SMN1; SMN2
SCHEMBL7975238 0.88 HPGD (0.45) GRIN1GRIN2BHPGDALDH1A1SMN1; SMN2
SCHEMBL7974245 0.88 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL7988732 0.88 ALDH1A1 (0.45) HPGDALDH1A1SMN1; SMN2KMT2ACYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed